OncoMatch/Clinical Trials/NCT05758688
PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
Is NCT05758688 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies non-drug interventions for cervical cancer.
This is a single institution, multi-center, Phase II, single-arm study, using Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT) in the post-surgical, adjuvant setting for definitive treatment of gynecologic cancers. The purpose of this study is to estimate rate of acute clinician-reported gastrointestinal (GI) toxicity using WP PBS PRT in the definitive treatment of gynecologic cancers in the post-surgical, adjuvant setting.
Check if I qualifyExtracted eligibility criteria
Cancer type
Cervical Cancer
Endometrial Cancer
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Prior therapy
Cannot have received: pelvic radiation
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Virtua Health · Voorhees Township, New Jersey
- Lancaster General Health - Ann B. Barshinger Cancer Institute · Lancaster, Pennsylvania
- University of Pennsylvania · Philadelphia, Pennsylvania
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify